|
1
|
Tzadok S, Beery E, Israeli M, et al: In
vitro novel combinations of psychotropics and anti-cancer
modalities in U87 human glioblastoma cells. Int J Oncol.
37:1043–1051. 2010.
|
|
2
|
Han L, Zhang K, Shi Z, et al: LncRNA
profile of glioblastoma reveals the potential role of lncRNAs in
contributing to glioblastoma pathogenesis. Int J Oncol.
40:2004–2012. 2012.PubMed/NCBI
|
|
3
|
Wang Y, Chen L, Bao Z, et al: Inhibition
of STAT3 reverses alkylator resistance through modulation of the
AKT and β-catenin signaling pathways. Oncol Rep. 5:1173–1180.
2011.PubMed/NCBI
|
|
4
|
Wang LF, Fokas E, Bieker M, et al: An HX
Increased expression of EphA2 correlates with adverse outcome in
primary and recurrent glioblastoma multiforme patients. Oncol Rep.
19:151–156. 2008.
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 23:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 16:350–355. 2004. View Article : Google Scholar
|
|
7
|
Grimson A, Farh KK, Johnston WK, et al:
MicroRNA targeting specificity in mammals: determinants beyond seed
pairing. Mol Cell. 27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–231. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim VN: MicroRNA biogenesis: coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao C, Tian F, Yu Y, et al:
miRNA-dysregulation associated with tenderness variation induced by
acute stress in Angus cattle. J Anim Sci Biotechnol. 3:12–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cuellar TL and McManus MT: MicroRNAs and
endocrine biology. J Endocrinol. 187:327–332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng H, Zhang L, Cogdell DE, et al:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ng EK, Chong WW, Jin H, et al:
Differential expression of microRNAs in plasma of patients with
colorectal cancer: a potential marker for colorectal cancer
screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rabinowits G, Gercel-Taylor C, Day JM, et
al: Exosomal microRNA: a diagnostic marker for lung cancer. Clin
Lung Cancer. 1:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Resnick KE, Alder H, Hagan JP, et al: The
detection of differentially expressed microRNAs from the serum of
ovarian cancer patients using a novel real-time PCR platform.
Gynecol Oncol. 112:55–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yaman Agaoglu F, Kovancilar M, Dizdar Y,
et al: Investigation of miR-21, miR-141, and miR-221 in blood
circulation of patients with prostate cancer. Tumour Biol.
32:583–588. 2011.PubMed/NCBI
|
|
19
|
Li W1, Yuan Y, Huang L, et al: Metformin
alters the expression profiles of microRNAs in human pancreatic
cancer cells. Diabetes Res Clin Pract. 96:187–195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roth P, Wischhusen J, Happold C, et al: A
specific miRNA signature in the peripheral blood of glioblastoma
patients. J Neurochem. 118:449–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kapranov P, Cheng J, Dike S, et al: RNA
map reveals new RNA classes and a possible function for persvasive
transcription. Science. 316:1484–1488. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Taft RJ, Pang KC, Mercer TR, et al:
Non-coding RNAs: regulators of disease. Pathology. 220:126–139.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang W, Edwards A, Fan W, et al:
miRNA-mRNA correlation-network modules in human prostate cancer and
the differences between primary and metastatic tumor subtypes. PLoS
One. 7:e401302012. View Article : Google Scholar
|
|
24
|
Williams AE: Functional aspects of animal
microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Place RF, Li LC, Pookot D, et al:
MicroRNA-373 induces expression of genes with complementary
promoter sequences. Proc Natl Acad Sci USA. 105:1608–1613. 2008.
View Article : Google Scholar
|
|
26
|
Brennecke J, Hipfner DR, Stark A, et al:
Bantam encodes a developmentally regulated microRNA that controls
cell proliferation and regulates the proapoptotic gene hid in
Drosophila. Cell. 113:25–36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: a new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Z, Gu X, Fang Y, et al: microRNA
expression profiles in human colorectal cancers with brain
metastases. Oncol Lett. 3:346–350. 2012.PubMed/NCBI
|
|
30
|
Díaz-Prado S, Cicione C, Muiños-López E,
et al: Characterization of microRNA expression profiles in normal
and osteoarthritic human chondrocytes. BMC Musculoskelet Disord.
13:1442012.PubMed/NCBI
|
|
31
|
Giles KM, Brown RA, Epis MR, et al:
miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem
Biophys Res Commun. 430:706–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong L, Han C, Zhang H, et al:
Construction of a recombinant lentivirus containing human
microRNA-7-3 and its inhibitory effects on glioma proliferation.
Neural Regener Res. 7:2144–2150. 2012.PubMed/NCBI
|
|
33
|
Bader AG, Brown D and Winkler M: The
promise of microRNA replacement therapy. Cancer Res. 70:7027–7030.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giles KM, Brown RA, Epis MR, et al:
miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem
Biophys Res Commun. 430:706–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McDonald JS, Milosevic D, Reddi HV, et al:
Analysis of circulating microRNA: preanalytical and analytical
challenges. Clin Chem. 57:833–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jorde R, Svartberg J, Joakimsen RM and
Coucheron DH: Plasma profile of microRNA after supplementation with
high doses of vitamin D3 for 12 months. BMC Res Notes. 5:2452012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Gelfond JA, McManus LM and
Shireman PK: Reproducibility of quantitative RT-PCR array in miRNA
expression profiling and comparison with microarray analysis. BMC
Genomics. 10:4072009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jensen SG, Lamy P, Rasmussen MH, et al:
Evaluation of two commercial global miRNA expression profiling
platforms for detection of less abundant miRNAs. BMC Genomics.
12:4352011. View Article : Google Scholar : PubMed/NCBI
|
